Post-GLP-1 Deflation
GLP-1 Recovery in Seoul
Layered Restoration Protocol
- Duration
- Consultation 30-45 min
- Sessions
- Sculptra 3 sessions × 4-6 weeks apart
- Downtime
- Bruising 3-7 days cannula / 5-7 days needle
GLP-1 Recovery Treatment in Seoul
GLP-1 face and body recovery hub in Gangnam — a Sculptra, Radiesse, and ONDA core layered protocol with HA and Thermage adjuncts, after Ozempic / Wegovy / Mounjaro weight loss.
- Duration
- 30–90 min+
- Sessions
- 1–3 (spaced 4–6 weeks apart)
- Downtime
- 3–7 days (mild bruising)
- Peak Result
- 6–12 months post-treatment
Results Over Time
Delight restores the face and body after GLP-1 weight loss using Sculptra, Radiesse, and ONDA. We do not prescribe medications; results require a 4–6 month timeline.
01Day 0
Immediate filler correction and mild swelling. Sculptra plumping is temporarily saline-driven — day-0 photos are not representative.
02Day 1–7
Swelling and bruising settle as HA filler stabilizes. Sculptra saline resorbs, leading to a temporary softening phase.
03Month 1–3
Sculptra PLLA and Radiesse CaHA begin fibroblast recruitment and collagen synthesis; Thermage RF remodeling builds up.
04Month 3–6
Visible Sculptra collagen response, peak Thermage firming, and improved body skin quality. Surface luminosity appears.
05Month 6–12+
Peak combined synergy matures. Results last 12–24 months; annual maintenance review recommended.
Images are AI-generated for illustrative purposes only.
GLP-1 Recovery Core Stack
Layered restoration after GLP-1 weight loss (Ozempic / Wegovy / Mounjaro). We do NOT prescribe GLP-1 medications — we restore the face and body after the effect, using Sculptra, Radiesse, and ONDA with HA and Thermage adjuncts.
Sculptra Foundation
PLLA biostimulator over 3 sessions — a collagen scaffold that rebuilds structure lost to rapid weight reduction.
Radiesse + ONDA
Hyperdilute Radiesse (CaHA) for body skin quality and ONDA Coolwaves for selective fat reduction and tightening.
HA + Thermage Adjuncts
HA filler for immediate targeted volume; Thermage FLX monopolar RF for comprehensive skin tightening.
Treatment Process
01Initial Assessment
Consultation + 30–45 min 4-layer anatomical mapping (volume / scaffold / laxity / surface). GLP-1 history reviewed with your prescribing physician.
02Treatment Plan
Layered plan — Sculptra foundation + targeted HA + Thermage FLX + hyperdilute Radiesse body + skin-booster series. Tailored to the deflation map.
03Patient Prep
NSAIDs / fish oil / vitamin E / garlic paused 7–10 days. Anticoagulation not stopped without prescriber clearance. HSV: valacyclovir prophylaxis.
04First Sculptra
Session 1 — 2 vials, high-dilution protocol. Cannula in vascular-risk zones; needle for deep boluses. '5-5-5 rule' aftercare. Not in lips or under-eyes.
05HA Filler
Same session or 1–2 weeks later — targeted volume in deep nasolabial / marionette / chin / tear trough. Cannula default, hyalase on-site. Reversible.
06Thermage FLX
4–8 weeks after Sculptra S1 (or a parallel visit). Total Tip 4.0 — immediate contraction plus 2–6 month remodeling.
07Additional Sculptra
Sessions 2–3 at Weeks 4–6 and 8–12, redistributed per visible response. Full arc = 3 sessions over 8–12 weeks.
08Body Radiesse
Hyperdilute Radiesse — 22G blunt cannula, subdermal fanning. Skin-quality, not volumetric. 2–3 sessions × 4–6 weeks. Off-label, disclosed.
Recovery & Care
Day 0 (24–72h vascular watch)
Emollient + SPF 50+, head elevated, cold compress. Sculptra '5-5-5' massage; NO massage after Thermage or Radiesse. Watch for blanching, dusky/mottled skin, severe pain, or vision change — 24/7 line for 72h.
Day 1–7
Avoid alcohol / sauna / exercise / high-dose fish oil. Strict SPF 50+, sun avoidance 14 days. Mild firmness expected. Continue GLP-1 medication per your physician.
Weeks 2–4
Resume normal skincare. Avoid dental cleaning 2 weeks / major dental work 4 weeks at the injection zone. Booster series monthly during the Sculptra arc.
Weeks 2–12
Delayed-inflammation watch: report any new lump, tenderness, color change, or systemic illness immediately — early intervention is better.
Frequently Asked Questions
Q.Should I stop GLP-1 before treatment?
Usually no. Moradi 2026 explicitly includes active-phase patients. Disclose full regimen at consultation — drug, dose, start date, current weight trajectory.
Q.Can the full restoration be done in one Seoul trip?
No. Sculptra arc alone is 3 sessions × 4-6 weeks. One trip covers Sculptra S1 + Thermage + targeted HA over 5-7 days. Remainder: return trips or competent home-country PLLA injector. 6-12 week extended stay alternative.
Q.Will facial volume return if I stop GLP-1?
Partially, only if you regain substantial weight, and unpredictably. Lean mass loss (~25% of total weight loss) is not restored automatically. Collagen scaffold change does NOT reverse with weight regain. Restoration addresses the structural change directly.
Q.Sequence — Sculptra, Radiesse, HA, or Thermage first?
Layered: (1) Sculptra foundation first (longest maturation). (2) Targeted HA same-session or 1-2 weeks later. (3) Thermage 4-8 weeks after Sculptra S1. (4) Hyperdilute Radiesse for body in parallel. (5) Skin booster monthly during Sculptra arc.
Q.Body skin laxity — arms, abdomen, buttocks?
Hyperdilute Radiesse + Thermage body. Body evidence is WEAKER than face (class-level consensus, not GLP-1-specific RCT). Patients seeking substantial body lift referred to plastic surgery for fat grafting evaluation.
Q.Is hyperdilute Radiesse a non-surgical BBL?
No. Lorenc 2022 + Galadari 2024 are explicit — skin-quality / laxity protocol, NOT volumetric augmentation. For volumetric BBL we refer to plastic surgery.
Q.Treat during active GLP-1 or wait for plateau?
Either is supported. Optimization: if actively losing, plan may need top-up sooner (further deflation). If plateaued ≥ 3-6 months, more aggressive first session OK. Pre-emptive treatment before deflation manifests not recommended.
Q.Why Seoul vs my home city?
Multi-modality access in one consult + dense specialist competition + cannula-first technique + hyperdilute body protocol familiarity + single-physician planning. Honest caveat — Sculptra / Radiesse are globally available; if your home city has a competent dermatologist familiar with the framework, Seoul is not the only option.
Q.Pricing? Insurance coverage?
Cosmetic — no insurance coverage even when underlying weight loss was medical. Per-session breakdown quoted in writing at consultation. Multi-session packages discount. Pre-trip virtual consult produces written quote.
Q.Is GLP-1 a Korean-approved indication for restoration?
GLP-1 medications are MFDS-approved for diabetes / chronic weight management (endocrinology scope). Our restoration services are NOT GLP-1-specific indications — used per existing aesthetic indications. We do NOT prescribe GLP-1.
Q.HA filler same day as Sculptra S1?
Yes, common pattern. Honest counsel: do NOT over-correct on HA expecting Sculptra to not deliver. Start conservative, see Sculptra response at S2 visit, adjust if more HA appropriate.
Q.Realistic 6 / 12 / 24-month outcome?
Month 1-3: Sculptra 'softening trough' (expected, not failure). Month 3-6: Sculptra collagen builds. Month 6-12 peak combined. Month 12-24: durability past 24 months for Sculptra. Touch-up typical 12-18 months.
Q.Most serious risk?
Vascular occlusion from HA / Radiesse (rare vision loss possible). Emergency protocol: immediate cessation, warm compress + nitroglycerin, hyaluronidase flooding, aspirin, ophthalmology referral within 60-90 min window. Sculptra-specific: nodule formation (modern higher-dilution reduces rates). 24/7 emergency contact for 72h.
Q.IV exosome / NAD+ / stem cell / IV GLP-1 booster?
No. We keep this hub within MFDS regulatory framework. IV exosome / stem cell / IV GLP-1 booster all NOT offered. Basic skin care hub covers IV Drip (vitamin C / glutathione / Cindella) as separate decision.
References14
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]Emergence of 'ozempic face' — addressing unintended consequences of rapid weight loss (letter documenting hollowing through cheeks and temples, increased jowling, deeper nasolabial and marionette lines, skin laxity, loss of luminosity 6-12mo after starting therapy). Ann Med Surg (Jodat) (2026).
- [2]Losing Weight and Gaining Wrinkles — impact of weight loss drugs on facial aesthetics (review documenting skin laxity, body contouring, facial volume loss with GLP-1 agonists; restoration with dermal fillers, biostimulator agents, skin-tightening tech). J Craniofac Surg (Barişkan) (2026).
- [3]Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients — multi-center experience-based framework (CITATION ANCHOR for layered protocol; eligibility does not typically differ in this group; multimodal approach with HA fillers + collagen-stimulating energy-based devices + skin-quality treatments). Aesthet Surg J Open Forum (Moradi) (2026).
- [4]Effects of GLP-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes — review of dermal white adipose tissue reduction and decreased collagen synthesis with rapid weight loss; clinically resembles accelerated skin aging. J Clin Med (Žaliukaitė) (2026).
- [5]'Ozempic Face' — Treatment with Endotissutal Bipolar Radiofrequency — case series n=24, 12mo follow-up, transient cutaneous erythema only adverse event, high satisfaction (face-only RF data; body laxity evidence weaker). J Clin Med (Catalfamo) (2025).
- [6]Effect of GLP-1 RAs and Co-Agonists on Body Composition — network meta-analysis n=2258, 22 RCT, semaglutide and tirzepatide most effective for weight + fat reduction but among least effective in preserving lean mass; ~25% of total weight loss is lean mass. Metabolism (Karakasis) (2024).
- [7]Incretin-Based Weight Loss Pharmacotherapy — Can Resistance Exercise Optimize Body Composition? Review documenting ~10% / 6kg lean mass loss comparable to a decade of aging; resistance training adjunct strategy. Diabetes Care (Locatelli) (2024).
- [8]Randomized study of injectable poly-L-lactic acid versus human-based collagen — 25-month nasolabial fold correction durability in PLLA arm (CITATION ANCHOR for Sculptra durability claim in restoration context). J Am Acad Dermatol (Narins) (2010).
- [9]Poly-l-lactic acid for HIV-1 facial lipoatrophy — 48-week follow-up randomized trial (CITATION ANCHOR for Sculptra HIV-lipoatrophy clinical home translating to GLP-1 deflation pathology; same disproportionate adipose loss with intact skin envelope). HIV Med (Carey) (2009).
- [10]Soft-tissue augmentation and the role of poly-L-lactic acid — review of PLLA mechanism, gradual controlled neocollagenesis around hydrolyzing microparticles, semipermanent results with favorable safety profile. Plast Reconstr Surg (Vleggaar) (2006).
- [11]Global expert consensus on diluted and hyperdiluted CaHA for skin tightening — CITATION ANCHOR for hyperdilute Radiesse body protocol off-label use. Dermatol Surg (Goldie) (2018).
- [12]Hyperdilute CaHA practical consensus — Type I collagen response, NO lymphocytic infiltrate, skin-quality protocol NOT volumetric augmentation (CITATION ANCHOR for honest body laxity framing). Aesthet Surg J (Lorenc) (2022).
- [13]CaHA for face — systematic review of off-label scope and RCT evidence gap (CITATION ANCHOR for honest framing that body protocols have weaker evidence than face). Int J Dermatol (Galadari) (2024).
- [14]Korea highest filler vision loss cohort — Asian-skin filler complications meta-analysis (CITATION ANCHOR for vascular safety protocol urgency). Aesthet Plast Surg (Kapoor) (2019).
Notice
- Pregnancy or breastfeeding
- Active skin infection or HSV at the site
- Hypersensitivity to PLLA, CaHA, CMC, HA, hyaluronidase, or lidocaine
- Active autoimmune flare, immunosuppression, or recent radiation — needs clearance
- Implanted electronic device in the Thermage RF field
- Therapeutic anticoagulation or recent dental work within 4 weeks — timing reviewed
- Active rapid weight loss without plateau — timing reviewed at consultation
Session summary & comparison
| Item | Details |
|---|---|
| What it is | A dermatologist-led (MD) layered restoration protocol for the face and body after rapid weight loss on GLP-1 medications (Ozempic / Wegovy / Mounjaro / Zepbound). We do not prescribe GLP-1 drugs — we treat their aesthetic after-effects |
| Core protocol | Sculptra (PLLA collagen biostimulator, 3 sessions) as the scaffold · Radiesse (CaHA, including hyperdilute use on the body — an off-label technique) · ONDA Coolwaves for residual fat pockets plus tightening · HA filler and Thermage FLX as adjuncts |
| Timeline (honest) | 'Rapid' applies to starting, not finishing — HA filler gives same-week volume for an event, but the Sculptra collagen arc needs 4-6 months to show; the peak combined result is typically at months 6-12 |
| During active GLP-1? | Usually fine — published experience-based guidance includes active-phase patients. If you are still losing, the plan builds in earlier top-ups; a weight plateau of 3-6 months supports a more definitive first session |
| One-trip feasibility | A 5-7 day Seoul trip covers Sculptra session 1 + Thermage + targeted HA filler; the remaining Sculptra sessions need return visits or a qualified injector at home |
Related procedures
Evidence & comparison guides
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step